caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1306822416

Pamela Adelstein

PRACTICEFENWAY HEALTHSee all providers at this practice →
Family PracticeBoston, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 220031
Hospital
CCN 220086
Hospital
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
744
Beneficiaries
—
Total drug cost
$104K
Distinct drugs
32
Brand share
18.1%
Top prescribed drugs
Atorvastatin Calcium65 claims
Omeprazole53 claims
Spironolactone49 claims
Gabapentin35 claims
Estradiol35 claims
REFERRAL NETWORK

Where Pamela Adelstein's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BOSTON MEDICAL CENTER37428
BOSTON MEDICAL CENTER CORPORATION24216
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
18131
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
BOSTON MEDICAL CENTER62830
BOSTON MEDICAL CENTER CORPORATION25262
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.